Fig. 2

Immunostaining of motor neuron-like cells derived from hBM-MSCs. The expression of Islet-1 (53 ± 10.1%), ChAT (45 ± 13.4%), and Mnx-1 antigens were investigated at the second week post-induction in the test group (treated hBM-MSCs) compared with the control group (non-treated hBM-MSCs)